
Bupropion Hydrochloride
150 mg/1 · Extended-Release Tablet
By Upsher-Smith Laboratories, LLC
- NDC
- 24979-101
- Route
- Oral
- Therapeutic class
- Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-06)NDC 24979-101-06Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-07)NDC 24979-101-07Available to order
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-02)NDC 24979-101-02Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

